Topics

Tyme Technologies, Inc. Company Profile

02:13 EST 15th December 2019 | BioPortfolio

Tyme, Inc. is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme, Inc. is the originator of what it believes to be a novel, proprietary treatment regimen consisting of a rationally-designed combination of therapeutic agents aimed at exploiting the aberrant metabolic characteristics of cancer cells as well as activating the endogenous immune response against tumors. Tyme, Inc.'s approach is hypothesized to permit selective elimination of cancer cells, while simultaneously improving patients' well-being, particularly with respect to pain severity and functional independence.


News Articles [247 Associated News Articles listed on BioPortfolio]

TYME Provides Updated Data on TYME-88-Panc Phase II Study

Tyme Technologies (NASDAQ:TYME) has provided an update on its open-label Phase 2 TYME-88-Panc study. As quoted in the press release: The data from the TYME-88-Panc study were presented at the European...

Tyme Technologies (TYME) Presents At BioNJ BioPartnering Conference - Slideshow

Tyme Technologies, Inc.'s (TYME) CEO Steve Hoffman on Q4 2019 Results - Earnings Call Transcript

Tyme Technologies, Inc. (TYME) CEO Steve Hoffman on Q2 2020 Results - Earnings Call Transcript

TYME Technologies Announces New Collaboration with NYU Langone to Advance TYME’s Cancer Metabolism-Based Therapy, SM-88

NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company, announced a new research collaboration with NYU Langone Health to advance th...

TYME Launches TYME-88-PANC Trial

The company's TYME-99-Panc trial will evaluate its candidate SM-88 in patients with metastatic pancreatic cancer. The post TYME Launches TYME-88-PANC Trial appeared first on Investing News Network.

TYME Technologies, NYU Langone to Advance Metastatic Cancer Treatment

Aims to examine TYME’s metabolism-based cancer treatment, SM-88

LineaRx signs agreement with TYME Technologies for functional invasive circulating tumour cell assay services in pancreatic cancer trial

Applied DNA Sciences announced that LineaRx, the Company’s majority-owned subsidiary focused on next-generation biotherapeutics and diagnostics, has signed a definitive agreement with Tyme Technolog...

PubMed Articles [347 Associated PubMed Articles listed on BioPortfolio]

Using structural diversity to measure the complexity of technologies.

The paper introduces structural diversity as a new approach to quantify the complexity of technologies. By modeling technologies as combinatorial networks, a measure of technological complexity is der...

The Price of Substitute Technologies.

Only a small share of new drugs is truly innovative; 85% to 90% of all new health technologies have little or no advantage over existing therapeutic alternatives. Health economic evaluations can be us...

Factors Influencing the Adoption of Smart Health Technologies for People With Dementia and Their Informal Caregivers: Scoping Review and Design Framework.

Smart Health technologies (s-Health technologies) are being developed to support people with dementia (PwD) and their informal caregivers at home, to improve care and reduce the levels of burden and s...

Special Issue: Drug Delivery Systems and Technologies Part I.

Empirical Research on Acceptance of Digital Technologies in Medicine Among Patients and Healthy Users: Questionnaire Study.

In recent years, interest in digital technologies such as electronic health, mobile health, telemedicine, big data, and health apps has been increasing in the health care sector. Acceptance and sustai...

Clinical Trials [583 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Registry for Real-world Experience of Catheter Ablation for Symptomatic Paroxysmal Atrial Fibrillation

The primary purpose of this registry is to obtain real-world clinical experience of Paroxysmal Atrial Fibrillation (PAF) ablation radiofrequency (RF) technologies. Data from the registry w...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Companies [1319 Associated Companies listed on BioPortfolio]

Tyme Technologies, Inc.

Tyme, Inc. is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme, Inc. is the origi...

LineaRx, Inc.

Tyme Technologies, Inc., is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike target...

Tyme, Inc.

Tyme is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme is the originator of wha...

Tyme Technologies Inc.

Tyme Technologies, Inc.

More Information about "Tyme Technologies, Inc." on BioPortfolio

We have published hundreds of Tyme Technologies, Inc. news stories on BioPortfolio along with dozens of Tyme Technologies, Inc. Clinical Trials and PubMed Articles about Tyme Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tyme Technologies, Inc. Companies in our database. You can also find out about relevant Tyme Technologies, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record